6[19]Mc Ginn TG,Guyatt GH,Wger PC,et al. Users'guides to themedical literature: X Ⅻ: how to use articles about clinicaldecisions rules [J]. JAMA,2000,284: 79～84.
7[20]Sackett D,Rosenberg WMC,Gray JAM,et al. Fvidcncc basedmedicine:what it is or what it isn't[J]. BMJ,1996,312:71～72.
8[21]Herzu M ,Ruppert V,Kuytz B,et al. Coxsackic B3 infection leadto cell death of cardiac myoctes [J]. J Nol Cell Cardiol, 1994,26:907～913.
9[22]Seko Y, Yamazaki T, Shinkai Y, et al. Celluar and molecularbases for the immunopathology of the mycardial cell damageinvolved in acute viral myocarditis with special reference todilated cardiomyopathy [J]. Jpn Circ J, 1992,56:1067～ 1072.
10[23]Joensuu H, Pylkkaenen L, Toikkanen S. Bcl-2 proteinexpression and long-term survival in breast cancel [J]. Am JPathol, 1994,145:1191 ～ 1194.
2WANG Wei-ting1,ZHAO Zhuan-you1,HAN Ying-mei2,XU Wei-ren2,TANG Li-da1 1.State Key Laboratory of Pharmacokinetics and Pharmacodynamics,Tianjin Institute of Pharmaceutical Research,Tianjin 300193,China 2.Tianjin Key Laboratory of Molecular Design & Drug Discovery,Tianjin Institute of Pharmaceutical Research,Tianjin 300193,China.Effects of Astragaloside Ⅳ Derivative on Heart Failure in Rats[J].Chinese Herbal Medicines,2010,2(1):48-53. 被引量：13
